Amylin, Amyloid and Age-Related Disease
- 1 January 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 9 (3), 202-212
- https://doi.org/10.2165/00002512-199609030-00006
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Effects of ciglitazone on endogenous plasma islet amyloid polypeptide and insulin sensitivity in obese-diabetic viable yellow miceLife Sciences, 1991
- Amylin or CGRP (8–37) fragments reverse amylin-induced inhibition of 14C-glycogen accumulationBiochemical and Biophysical Research Communications, 1991
- Amylin secretion from the perfused pancreas: Dissociation from insulin and abnormal elevation in insulin-resistant diabetic ratsBiochemical and Biophysical Research Communications, 1991
- Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agentsBiochemical and Biophysical Research Communications, 1991
- Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1991
- Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanismBiochemical and Biophysical Research Communications, 1991
- Angiotensin Converting Enzyme Inhibitors and Moderate HypertensionDrugs, 1990
- Islet amyloid polypeptide (IAPP;Amylin) influences the endocrine but not the exocrine rat pancreasBiochemical and Biophysical Research Communications, 1990
- Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1989
- Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic isletsBiochemical and Biophysical Research Communications, 1989